 Pfizer Inc explored a potential taxlowering takeover of rival Actavis PLC in recent weeks but talks between the two pharmaceutical companies have ended according to a person familiar with the matter New Yorkbased Pfizer approached Actavis proposing a cashandstock tieup according to the person The talks ended last week after Actavis decided against a deal the person said It is unclear why Actavis has a market value of about  billion